| Literature DB >> 32214664 |
Maya Puspita1,2, Maureen Déniel1,3, Ita Widowati2, Ocky Karna Radjasa2, Philippe Douzenel1, Christel Marty1, Laurent Vandanjon1,3, Gilles Bedoux1, Nathalie Bourgougnon1.
Abstract
Seaweeds are potentially excellent sources of bioactive metabolites that could represent useful leads in the development of new functional ingredients in pharmaceutical and cosmetic industries. In the last decade, new marine bioprocess technologies have allowed the isolation of substances with biological properties. The brown alga Sargassum muticum (Yendo) Fensholt (Ochrophyta) was enzymatically hydrolyzed to prepare water-soluble extracts by using six different commercially available carbohydrate-degrading enzymes and two proteases. Evaluation of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) antioxidant, tyrosinase, elastase, and biofilm inhibition, antibacterial and antiviral activities as well as evaluation of cytotoxicity were realized for each extract. Total phenolic content was measured for extract characterization, and solid-phase extraction was useful to purify the enzymatic extract. Soluble total phenolic content of S. muticum Viscozyme extract was highest with 6.4% of dry weight. Enzymatic Celluclast and Viscozyme extracts had the lowest value of DPPH IC50 indicating a strong antiradical activity, 0.6 mg mL-1, in comparison with other enzymes. The ferric reducing antioxidant power ranged between 48.7 μM Fe2+ Eq, digested with Viscozyme, and 60.8 μM Fe2+ Eq, digested with Amyloglucosidase. Tyrosinase inhibition activity of S. muticum Neutrase extract was 41.3% higher compared to other enzymes. Elastase inhibition activity of S. muticum Shearzyme extract had highest activity (32.8%). All enzymatic extracts showed no cytotoxic effect towards the kidney Vero cells. Meanwhile, only S. muticum Neutrase and Alcalase extracts exhibited potential antiviral activity. In addition, S. muticum Viscozyme and Shearzyme extracts showed promising activity in suppressing the biofilm formation against Pseudomonas aeruginosa and Escherichia coli, respectively. Purification of S. muticum Viscozyme extracts by solid-phase extraction managed to concentrate the phenolic content and improve the bioactivity. These results indicate the promising potential of enzyme-assisted followed by solid-phase extraction in recovering phenolic content and in improving its bioactivity. © Springer Science+Business Media Dordrecht 2017.Entities:
Keywords: Bioactivities; Carbohydrase; Enzyme-assisted extraction; Phaeophyceae; Protease; Solid-phase extraction
Year: 2017 PMID: 32214664 PMCID: PMC7088061 DOI: 10.1007/s10811-017-1086-6
Source DB: PubMed Journal: J Appl Phycol ISSN: 0921-8971 Impact factor: 3.215
Fig. 1Enzyme-assisted extraction of S. muticum
Fig. 2Yield of enzyme-assisted extraction of S. muticum (there is no significant difference between tested samples, p > 0.05). Aqueous extraction was used as control
Soluble total phenolic content, DPPH IC50, FRAP, tyrosinase, and elastase inhibition activity of S. muticum enzymatic extracts
| Samples | Soluble TPC ( % of dry algal material) | DPPH IC50 (mg mL−1) | FRAP (μM Fe2+ Eq) | Tyrosinase inhibition activity (% of inhibition) | Elastase inhibition activity (% of inhibition) | ||||
|---|---|---|---|---|---|---|---|---|---|
| BHA | 0.008 ± 0.5 | Vitamin C | 58.1 ± 0.7 | Kojic acid | 67.6 ± 6.5 | Trypsin inhibitor | 50.0 ± 0.0 | ||
| BHT | 0.012 ± 4.8 | Quecertin | 42.7 ± 9.4 | ||||||
| Control | 2.6 ± 0.0a | 0.7 ± 0.2a | 65.7 ± 1.0a | 14.7 ± 3.1a | 23.1 ± 4.8ac | ||||
| Neutrase | 3.8 ± 0.0ac | 0.9 ± 0.1a | 58.8 ± 0.6bd | 6.6 ± 1.5b | 23.4 ± 3.3ac | ||||
| Ultraflo | 4.2 ± 0.0ac | 2.2 ± 0.9c | 58.4 ± 0.8b | 24.5 ± 2.6c | 24.0 ± 4.2ac | ||||
| Alcalase | 3.8 ± 0.0ac | 1.9 ± 0.3bc | 56.1 ± 3.0c | 10.7 ± 3.5a | 30.9 ± 5.9ac | ||||
| Celluclast | 4.5 ± 0.0bc | 0.6 ± 0.1a | 59.3 ± 1.7bd | 19.9 ± 5.1a | 29.9 ± 0.5ac | ||||
| AMG | 4.8 ± 0.0bc | 0.7 ± 0.3a | 60.8 ± 1.8ad | 15.4 ± 2.3a | 21.6 ± 0.8a | ||||
| Shearzyme | 4.7 ± 0.0bc | 1.0 ± 0.3ab | 58.4 ± 0.7bd | 13.0 ± 0.7a | 32.8 ± 0.9bc | ||||
| Viscozyme | 6.4 ± 0.5bc | 0.6 ± 0.1a | 48.7 ± 0.9c | 23.5 ± 2.6c | 29.7 ± 1.9ac | ||||
| Termamyl | 5.0 ± 0.1bc | 0.8 ± 0.2a | 57.4 ± 1.0b | 14.2 ± 2.5a | 28.7 ± 3.8ac | ||||
Each value represented is mean ± standard deviation (n = 3), distinguished by different superscript letters in order to indicate a significant difference (p < 0.05)
IC inhibitory concentration 50 %—concentration needed to inhibit 50 % of the reaction, Eq equivalent
Antiviral and biofilm inhibition activity of S. muticum enzymatic extract
| Samples | Biofilm inhibition activity (% of inhibition) | Antiviral activity | |||
|---|---|---|---|---|---|
|
|
| CC50 (μg mL−1) | EC50 (μg mL−1) | ||
| Zovirax | >500 | 0.7 ± 0.3 | |||
| Control | n.a. | 14.7 ± 0.9a | >500 | >500 | |
| Neutrase | 36.1 ± 7.8a | 29.1 ± 10.0ac | >500 | 430.1 ± 16.3 | |
| Ultraflo | 3.7 ± 2.0b | 32.8 ± 3.7ac | >500 | >500 | |
| Alcalase | n.a. | 38.0 ± 7.9b | >500 | 225.1 ± 23.3 | |
| Celluclast | n.a. | 33.8 ± 7.7a | >500 | >500 | |
| AMG | n.a. | 43.2 ± 5.9be | >500 | >500 | |
| Shearzyme | 26.9 ± 2.1b | 64.3 ± 10.3de | >500 | >500 | |
| Viscozyme | 43.7 ± 4.2a | 28.8 ± 9.4a | >500 | >500 | |
| Termamyl | 12.4 ± 3.9b | 49.2 ± 13.3be | >500 | >500 | |
Each value represented is mean ± standard deviation (n = 3), distinguished by different superscript letters in order to indicate a significant difference (p < 0.05)
CC cytotoxic concentration 50 %—a concentration of product generating 50 % of cell viability compared to control, EC antiviral effective concentration—a concentration of product causing 50 % of inhibition of HSV-induced destruction towards the cells, n.a. no activity detected
Fig. 3Principal component analysis of S. muticum. a From all FT-IR spectra (600–1800 cm−1). b Phenolic compound of enzymatic extraction from the selected FT-IR spectra (865–880, 920–935, 1075–1090, 1445–1460, 1605–1620, 2930–2945, 3200–3300 cm−1). ALC Alcalase; AMG Amyglucosidase, NEU Neutrase; TN control/aqueous extract, CEL Celuclast, SHE Shearzyme, TER Termamyl, ULT Ultraflo, VIS Viscozyme
Identified wave numbers of Viscozyme extracts (raw and purified sample) correspond to the phenolic compounds
| Wave number (cm−1) | Bonds | References |
|---|---|---|
| 873.72a | C–H aromatics | Haeuser et al. ( |
| 887.07b | ||
| 899.15a | C=CH2 | Karunakaran et al. ( |
| 930.47a | Vibration C–O–C | Sekkal et al. ( |
| 932.22b | ||
| 1081.72a | C–O stretch | Gómez-Ordóñez and Rupérez ( |
| 1075.70b | ||
| 1325a | C–H deformation | Gómez-Ordóñez and Rupérez ( |
| 1450.96a | δ CH2–CH3 bend | Sigee et al. ( |
| 1493.98b | ||
| 1618.11a | C=C cyclic | Kusumaningsih et al. ( |
| 1617.51b | ||
| 2934.75a | C–H stretch | Ahn et al. ( |
| 2935.76b | ||
| 3239.54a | O–H stretch | Standard (phloroglucinol) |
| 3227.27b |
aRaw hydrolysate
bPurified hydrolysate
Fig. 4Chromatogram of S. muticum from HPLC analysis. a S. muticum Viscozyme raw extract overlaid with phloroglucinol detected at 280 nm. b Purified fraction of S. muticum Viscozyme extract shows a well-separated fraction that is previously assumed to have aromatic rings same as phloroglucinol